Metaphase Design Group, Inc. is a leader in applying the science of human factors engineering and ergonomics to product design. Metaphase incorporates various areas of specialization in their User-Centered Design Innovation Process, combining them with extensive expertise in Industrial Design and Human Factors research and support.READ MORE >>
Benchmark International has successfully facilitated the acquisition of Comprehensive Clinical Trials, LLC and Advanced Clinical Trials, LLC (hereinafter referred to as CCT) by Vitalink Research, LLC. (hereinafter referred to as Vitalink).
CCT is an accomplished clinical research site specializing in conducting Phase II - IV clinical trials. It serves over 400 sponsors ranging from small biotech companies to the world's largest pharmaceutical and medical device companies and has completed hundreds of trials.
Vitalink is a US network of fully integrated clinical trial sites, connects world-class physicians and medical professionals with site managers and research coordinators to set the standard for the timely execution of clinical trial protocols with trustworthy results across all sites.
“I am excited to partner with the entire VitaLink Research team to further grow our combined business over the coming years,” said Dr. Ronald Ackerman, Founder and Medical Director of CCT. “From my first meeting with VitaLink, it was clear that we shared a common culture rooted in clinical excellence and quality patient care. I look forward to this next chapter for myself and my dedicated staff”
“The partnership with Comprehensive Clinical Trials enables VitaLink to further establish itself as one of the leading wholly- owned clinical research site companies in the Southeast,” said Nick Wright, CEO of VitaLink Research. “The addition of CCT partners VLR with the fantastic team that Dr. Ronald Ackerman has built throughout his distinguished career as a physician and Principal Investigator. This partnership expands our therapeutic capabilities into a very important and growing area of drug development research and our geographic footprint.”
“I’m very excited for both CCT and VitaLink for consummating this partnership. As with every deal, this transaction faced a small number of issues through the diligence process. Thankfully, both sides had practiced professionals which allowed us to work through the various issues and find a way to make both sides happy. With this acquisition, VitaLink will break into theWomen’s Health sector with a major statement. Through the leadership of Dr. Ackerman, Vitalink will quickly become a widely recognized leader in this highly specialized study area.” said Benchmark International Associate Transaction Director David Steverson.
Benchmark International has successfully facilitated the transaction between Advanced Renal Care, Inc. and Fresenius Medical Care of North America. Fresenius Medical Care of North America is one of the largest dialysis providers in north America. Advanced Renal Care, Inc. is a dialysis provider in Tampa, Florida.
Dr. Stanley Dennison, CEO and Owner of Advanced Renal Care, Inc. stated, “I would like to thank Benchmark International for their drive, and focus on closing this transaction. This transaction faced difficulties at times. The Benchmark International team always stayed focused, and did not falter in the time of need.”
“We are truly excited to have acquired Advanced Renal Care, Inc. This presents a fantastic opportunity for Fresenius Medical Care to treat new patients,” stated Erik Lyesiuk, Senior Director of Mergers & Acquisitions of Fresenius Medical Care.
Benchmark International Director Dara Shareef stated, “We would like to congratulate both Advanced Renal Care, Inc. and Fresenius Medical Care of North America. This acquisition is a terrific strategic move for Fresenius Medical Care, allowing them to enter the Tampa Bay market. The buyer truly valued our clients location and access to major hospitals in the area. We feel this deal was win-win for both sides and wish all the best in the future.”READ MORE >>